# Amphastar Pharmaceuticals, Inc.: Form 8-K, filed Feb 27, 2025

- Company: [Amphastar Pharmaceuticals, Inc.](/companies/amph.md) (CIK 1297184)
- Form: 8-K
- Filed: 2025-02-27
- Accepted by EDGAR: Feb 27, 2025, 16:33 ET
- Period: 2025-02-27
- Accession: 0001297184-25-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1297184/000129718425000003/amph-20250227x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1297184/000129718425000003/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1297184/000129718425000003/amph-20250227x8k.htm

Filed Feb 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001297184-25-000003. Last ingested by Listed: Nov 6, 2026, 17:01 ET. No prices; not investment advice.
